252 related articles for article (PubMed ID: 27988353)
1. The effects of urotensin II on migration and invasion are mediated by NADPH oxidase-derived reactive oxygen species through the c-Jun N-terminal kinase pathway in human hepatoma cells.
Li YY; Shi ZM; Yu XT; Feng P; Wang XJ
Peptides; 2017 Feb; 88():106-114. PubMed ID: 27988353
[TBL] [Abstract][Full Text] [Related]
2. Urotensin II-induced insulin resistance is mediated by NADPH oxidase-derived reactive oxygen species in HepG2 cells.
Li YY; Shi ZM; Yu XY; Feng P; Wang XJ
World J Gastroenterol; 2016 Jul; 22(25):5769-79. PubMed ID: 27433090
[TBL] [Abstract][Full Text] [Related]
3. Urotensin-II-Mediated Reactive Oxygen Species Generation via NADPH Oxidase Pathway Contributes to Hepatic Oval Cell Proliferation.
Yu X; Wang P; Shi Z; Dong K; Feng P; Wang H; Wang X
PLoS One; 2015; 10(12):e0144433. PubMed ID: 26658815
[TBL] [Abstract][Full Text] [Related]
4. Hydrogen peroxide inducible clone-5 mediates reactive oxygen species signaling for hepatocellular carcinoma progression.
Wu JR; Hu CT; You RI; Pan SM; Cheng CC; Lee MC; Wu CC; Chang YJ; Lin SC; Chen CS; Lin TY; Wu WS
Oncotarget; 2015 Oct; 6(32):32526-44. PubMed ID: 26416447
[TBL] [Abstract][Full Text] [Related]
5. Urotensin II inhibits skeletal muscle glucose transport signaling pathways via the NADPH oxidase pathway.
Wang HX; Wu XR; Yang H; Yin CL; Shi LJ; Wang XJ
PLoS One; 2013; 8(10):e76796. PubMed ID: 24116164
[TBL] [Abstract][Full Text] [Related]
6. Dihydromyricetin inhibits migration and invasion of hepatoma cells through regulation of MMP-9 expression.
Zhang QY; Li R; Zeng GF; Liu B; Liu J; Shu Y; Liu ZK; Qiu ZD; Wang DJ; Miao HL; Li MY; Zhu RZ
World J Gastroenterol; 2014 Aug; 20(29):10082-93. PubMed ID: 25110435
[TBL] [Abstract][Full Text] [Related]
7. Induction of hepatoma carcinoma cell apoptosis through activation of the JNK-nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-ROS self-driven death signal circuit.
Zeng KW; Song FJ; Wang YH; Li N; Yu Q; Liao LX; Jiang Y; Tu PF
Cancer Lett; 2014 Oct; 353(2):220-31. PubMed ID: 25064608
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of urotensin II and its receptor contributes to human hepatocellular carcinoma growth via activation of the PKC, ERK1/2, and p38 MAPK signaling pathways.
Yu XT; Wang PY; Shi ZM; Dong K; Feng P; Wang HX; Wang XJ
Molecules; 2014 Dec; 19(12):20768-79. PubMed ID: 25514221
[TBL] [Abstract][Full Text] [Related]
9. Activation of NADPH/ROS pathway contributes to angiogenesis through JNK signaling in brain endothelial cells.
Wang Z; Yang J; Qi J; Jin Y; Tong L
Microvasc Res; 2020 Sep; 131():104012. PubMed ID: 32428522
[TBL] [Abstract][Full Text] [Related]
10. Urotensin II inhibited the proliferation of cardiac side population cells in mice during pressure overload by JNK-LRP6 signalling.
Chen Z; Xu J; Ye Y; Li Y; Gong H; Zhang G; Wu J; Jia J; Liu M; Chen Y; Yang C; Tang Y; Zhu Y; Ge J; Zou Y
J Cell Mol Med; 2014 May; 18(5):852-62. PubMed ID: 24447593
[TBL] [Abstract][Full Text] [Related]
11. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways.
Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F
Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636
[TBL] [Abstract][Full Text] [Related]
12. Sorafenib inhibits migration and invasion of hepatocellular carcinoma cells through suppression of matrix metalloproteinase expression.
Ha TY; Hwang S; Moon KM; Won YJ; Song GW; Kim N; Tak E; Ryoo BY; Hong HN
Anticancer Res; 2015 Apr; 35(4):1967-76. PubMed ID: 25862849
[TBL] [Abstract][Full Text] [Related]
13. Distinct roles of Akt1 in regulating proliferation, migration and invasion in HepG2 and HCT 116 cells.
Chen L; Kang QH; Chen Y; Zhang YH; Li Q; Xie SQ; Wang CJ
Oncol Rep; 2014 Feb; 31(2):737-44. PubMed ID: 24297510
[TBL] [Abstract][Full Text] [Related]
14. Glabridin inhibits migration and invasion by transcriptional inhibition of matrix metalloproteinase 9 through modulation of NF-κB and AP-1 activity in human liver cancer cells.
Hsieh MJ; Lin CW; Yang SF; Chen MK; Chiou HL
Br J Pharmacol; 2014 Jun; 171(12):3037-50. PubMed ID: 24641665
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside-Rg3 inhibits the proliferation and invasion of hepatoma carcinoma cells via regulating long non-coding RNA HOX antisense intergenic.
Pu Z; Ge F; Wang Y; Jiang Z; Zhu S; Qin S; Dai Q; Liu H; Hua H
Bioengineered; 2021 Dec; 12(1):2398-2409. PubMed ID: 34130594
[TBL] [Abstract][Full Text] [Related]
16. ASTN1 is associated with immune infiltrates in hepatocellular carcinoma, and inhibits the migratory and invasive capacity of liver cancer via the Wnt/β‑catenin signaling pathway.
Chen QF; Shi F; Huang T; Huang C; Shen L; Wu P; Li W
Oncol Rep; 2020 Oct; 44(4):1425-1440. PubMed ID: 32945491
[TBL] [Abstract][Full Text] [Related]
17. c-Jun NH2-terminal kinase pathway is involved in constitutive matrix metalloproteinase-1 expression in a hepatocellular carcinoma-derived cell line.
Sugioka Y; Watanabe T; Inagaki Y; Kushida M; Niioka M; Endo H; Higashiyama R; Okazaki I
Int J Cancer; 2004 May; 109(6):867-74. PubMed ID: 15027120
[TBL] [Abstract][Full Text] [Related]
18. Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression.
Hsieh SC; Tsai JP; Yang SF; Tang MJ; Hsieh YH
Amino Acids; 2014 Dec; 46(12):2809-22. PubMed ID: 25245054
[TBL] [Abstract][Full Text] [Related]
19. [Trametenolic acid inhibits migration and invasion of hepatocellular carcinoma HepG2.2.15 cells via RhoC/ROCK1 pathway].
Wan YL; Wang JZ; Yuan Y; Ye WY; Li HL; Zhang XL; Zhang HQ; Li LE
Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(1):185-196. PubMed ID: 38403351
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis induced by a new flavonoid in human hepatoma HepG2 cells involves reactive oxygen species-mediated mitochondrial dysfunction and MAPK activation.
Liu H; Xiao Y; Xiong C; Wei A; Ruan J
Eur J Pharmacol; 2011 Mar; 654(3):209-16. PubMed ID: 21241688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
